|

Flavay's
strong antioxidant power is patentedas a scavenger
of the free radicals that play a major role in the degradation of
collagen and initiation, duration and breakdown of inflammation.
That means that your joints hurt less and your blood flows
better...
Originally patented and licensed in France for therapeutic uses, Flavay
is the very productused in the actual experimentsby which
Dr. Jack Masquelier established and patented the "radical scavenger
effect."
"[A] method for preventing and fighting the harmful
biological effects of free radicals in the organism of
warm blooded animals and more especially human beings, namely
cerebral involution, hypoxia following atherosclerosis, cardiac
or cerebral infarction, tumour promotion, inflammation,
ischaemia, alterations of the synovial liquid, collagen
degradation, among others. The method consists in administering
to said animals and especially to human beings an amount, efficient
against said effects, of a plant extract with a proanthocyanidins
content which has a radical scavenger effect"Dr.
Jack Masquelier, U.S. Patent No. 4,698,360.
|
During any challenge to your immune systembecause of disease, infections,
toxic exposure, stress or agingyou need the extra antioxidant power
in Flavay
to help scavenge the free radicals naturally produced by the
immune system's cells during warfare.
Antioxidants vs. Free Radicals
Antioxidants fight corrosive and destructive forces that constantly work
to break down our bodies. Overwhelming scientific evidence demonstrates
that those of us who eat a diet rich in antioxidants and take antioxidant
supplements will live longer and healthier lives. Working as a defensive
army, antioxidants work together in the body to maintain our health and
vigor by protecting us from damage caused by rampaging free radicals which,
like terrorists, injure healthy cells and tissues.
Don't underestimate the threat that free radicals pose to our health.
Contemporary scientists now believe that free radicals are causal factors
in nearly every known disease, from heart disease to arthritis to cancer
to cataracts to the aging process itself.
Where do free radicals come from? The body produces free radicals in
the normal course of energy production and there are substances in our
environment (chemicals in our foods and beverages, medications, extremely
reactive air pollutants from vehicle exhaust, and even solar radiation)
that trigger the production of free radicals.
Free Radicals: Both Foe and Friend
to the Immune System and Brain Function
When the body fights off an infection, the immune system's cytokines
go to work, sending messages to the brain that cause more white blood
cells to mobilize. The more white blood cells your body activates, the
more free radicals they produce, like pellets of poison, that go to work
to destroy invaders by breaking down the genetic material of bacteria,
toxins, and viruses.
When functioning properly, the immune system is capable of identifying
foreign invaders such as viruses and bacteria and our immune components
do not turn against our own body's cells. Unfortunately, however, free
radicals can interfere with the biological components of our healthy cells
in the same way they destroy invaders, literally dismantling the body's
essential cellular proteins, fatty cell membranes and DNA.
The most important natural defenses we have against free radical damage
are our body's natural "antioxidants," a broad range of chemical
substances that all have one thing in common: they ward off free radical
damage to cells. However, in many neurological diseasesincluding
Parkinson's, Alzheimer's, chronic fatigue, and multiple sclerosisthe
brain's specialized antioxidant mechanisms fail. The cause of the failure
might be genetic, environmental, or even dietary, but the consequences
are the same: unchecked free radical activity on the brain.
Some free radicals are beneficial in the body, such as nitric oxide,
which acts as a neurotransmitter when the immune system is functioning
properly. Unfortunately, the excessive production of nitric oxide can
also be blamed for throwing the brain-immune systems off kilter and causing
some of the brain's worst free radical damage. Over the past decade, scientists
have shown that the production of nitric oxide through a combination of
immune and nervous system activityoften sparked by an infection,
exposure to a toxin, or as part of the aging processplays a key
role in the development of neurological diseases.
Free Radicals: Both Foe and Friend
to the Cardiovascular System
Free radicals are involved in the progression of heart disease in several
different ways. Heart disease begins with the oxidation of LDL (low-density
lipoproteins) cholesterol which leads to the formation of plaque in the
arteries. If an artery becomes clogged with plaque, the result can be
a heart attack (a sudden loss of blood and oxygen to the heart) or a stroke
(loss of blood to the brain). Much of the damage that occurs in both heart
attacks and strokes is caused by reperfusion injury: the burst
of superoxide free radicals that flow in as the blood flow resumes.
Contemporary scientific studies have established another way in which
free radicals can promote atherosclerosis (hardening of the arteries),
and how one free radical in particularnitric oxidemay play
a central role. Nitric oxide is essential for normal blood circulation
as it controls the muscular tone of blood vessels and regulates circulation
and blood flow. But excessive amounts of nitric oxide can be very destructive
as it can restrict blood flow and promote production of more free radicals,
contributing to heart disease and stroke. Thus, in order to have good
circulatory health, the body must maintain the right balance of nitric
oxideand that's the role of the antioxidants and their boosters.
Free Radicals and Chronic Inflammation
Inflammation is caused by the overproduction of free radicals in a specific
area of the body. The inflammatory response is a factor in arthritis,
an umbrella term for more than 100 different diseases that produce either
inflammation of the connective tissue (joints and tendons) or degeneration
of the articular cartilage (a wearing down of the protective covering
that cushions the end of bones, allowing bones to rub together without
causing damage to the joints). When joints become arthritic, they become
inflamed and enlarged, interfering with the normal flow of blood. For
example, bending an arthritic knee restricts blood flow to the area. As
in the case of stroke and heart attack, when blood flow is cut off, it
sets into motion a chain of events that will lead to a burst of free radicals
when blood flow returns. The proliferation of free radicals causes a one-two
punch as the area to become even more inflamed, contributing to the degeneration
of the joint, which becomes more swollen and worn down.
The key to good health is to maintain the right balance between antioxidants
and free radicals.
Flavay is Your Best Weapon Against
Toxic Free Radicals
Flavay is superior to other antioxidants
because its protective effects are multiplied in the body: while it provides
its own, powerful antioxidant protection, it also supports the dynamic
interplay between other antioxidants in the body. Flavay's ability to
recycle, or regenerate vitamins C and E after they have quenched
free radicals vastly extends their unique antioxidant powers, helping
the body to maintain its synergistic antioxidant balance.
Flavay is rapidly absorbed and very quickly distributed throughout the
body. As a free radical fighter, Flavay comes to the aid of the body more
quickly than other antioxidants, reducing the potential for free radical
damage and the ravages of aging. Flavay also possesses more reactive sites
for neutralizing free radicals than other known antioxidants. Furthermore,
Flavay permits reactivity with both positively and negatively charged
free radical species. What this means is that Flavay can quench
or scavenge (neutralize) a broad variety of free radicals.
Highly reactive as an antioxidant in both lipid (fat) and aqueous (water)
phases, Flavay neutralizes oxygen free radicals and is a valuable protector
of healthy cells in a variety of internal conditions. This is a unique
property among antioxidants, as most work either in lipid or aqueous phases,
but not both.
Flavay helps to modulate the effects of nitric oxide, an important free
radical produced by the body. As discussed above, some nitric oxide is
essential, but too much can kill cells. Research demonstrates that Flavay
can help to maintain the optimal level of this free radical by helping
the body produce adequate levelsand neutralize nitric oxide where
it does harm.
Research also demonstrates that Flavay can quench superoxide and the
hydroxyl radical. This is extremely important. Of all the free radicals
formed in the body, the hydroxyl radical is the most dangerous because
it can directly attack DNA. As a free radical scavenger, Flavay is like
an antioxidant prize fighter that can successfully take on all challengers,
big or small, in any kind of weather.
Antioxidants Work Together in the BodyNot
Alone
Current research demonstrates that key antioxidants and their co-factor
nutrients work synergistically with one another in the body. Flavay
Plus utilizes this dynamic interplay among the antioxidants
and their co-factor nutrients with a synergistic blend of Flavay
and antioxidant vitamins and minerals and phytonutrients; formulated to
boost the brain and immune functionsthereby benefiting the whole
body.
Patented Antioxidant Power—Plus
Flavay's™ strong antioxidant power is patented—as a scavenger
of the free radicals that play a major role in the degradation of collagen
and the initiation, duration and breakdown of inflammation. That means
that your immune system works better, your joints hurt less, and your
blood flows better, all because of Flavay™.
And now, Flavay
Plus™ takes advantage of the dynamic interplay between Flavay™
and the other antioxidant nutrients and their co-factors in a blend that
provides you and your family with the best that nutritional science has
to offer for antioxidant protection—in a convenient, cost effective
capsule.
CLICK
HERE TO SEE WHAT ACTUAL CUSTOMERS ARE SAYING
Statements made herein have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
|
REFERENCES:
Top
|
Masquelier, J. Plant extract with
a proanthocyanidins content as a therapeutic agent having radical scavenging
effect and use thereof. U.S. Patent No. 4,698,360, 1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega
Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega
Editrice, Publishers,
1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
Mindell, E., et al. Earl Mindells vitamin bible for the 21st century.
Warner Books, Inc., 1999.
Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats
Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Lieberman, S., et al. The real vitamin & mineral book: going beyond
the RDA. Avery Pub., 1990.
Facino RM, et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from Vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant to the
action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres
procyanidoliques.
Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains
flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres
flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de laction des
oligomeres procyanidoliques sur des cellules mesenchymateuses en culture.
Ii lattachment des fibres elastiques aux cellules. (Study of the effect
of procyanidolic oligomers on mesenchymal cells in culture. Ii attachment
of elastic fibers to the cells.) Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and crystal
structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3,
4.4, 5.7-Hexahydroxyflavan] dihydrate, and comparison of its
heterocyclic ring conformation in solution and the solid state. Journal
of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free radicals.
Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins b-1 and
b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990.
pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different procyanidins
from grape seeds. Presented at a symposium, Free radicals in biotechnology
and medicine. Royal Society Of Chemistry, London January 1990, pp.
79-80.
Bauman, J., Wurm, G., Bruchhausen, F. Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp., 1998.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin
becomes resistant to the action of mammalian collagenase. Experientia, 37:
221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm
Arom, 95: 89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies that binding
of pycnogenols to elastin affects its rate of degradation by elastases.
Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted
from vitus vinifera l. in the rat. European Journal of Drug
Metabolism and Pharmaccokinetics. 1978, No. 1 pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging activity
of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo
and in vitro study. Cosmetology Department & S Biovectors, Ramonville
St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i converting
enzyme by flavanolic compounds: in vitro and in vivo studies. Planta
Medica,
May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-oedenme de la patte. Sanofi Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-activite aniagoniste vis-a-vis des mediateurs de linflamation.
Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance
capillaire,
spontanement ou artificiellement diminuee par laction dune substance
capillaro-toxique chez des personnes agees--action benefique dun agnet
actif sur la micro-circulation: lEndotelon. Inform. Therapeut. 1980.
pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude dun
microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. Etude des effets des oligomeres
du procyanidol sur las resistance capillaire dand lhypertension arterielle
et certaines nephropathies. Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique dun angioprotecteur
peripherique,
lEndotelon. Actualite Therapeutique Gaz. Med. de France (87)22:2919-24,
1980.
Lesbre, F.X., Tigaud, J.D. Effect de lEndotelon sur lindice
de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres inferieurs
par un microangioprotecteur lEndotelon. Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de lEndotelon dans linsuffisance
veineuse chronique. Therapeutique, la Revue de Medicine, (27-28) Sept. 1981.
pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de lEndotelon dand les manifestations
fonctionnelles de linsuffisance veineuse peripherique-resultats dune
etude en double aveugle portant sur 92 patients. Gazette Medicale,
(92)1, 1985. pp. 96-100.
Wegrowski, J., Robert, A.M., Maczar, M. The effect of procyanidolic oligomers
on the composition of normal and hypercholesterolemic rabbit aortas.
Biochem. Pharmacol, (33)21. 1984. pp. 3491-3497.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and arachidonate
metabolism in platelets by procyanidins. Prostagland Leukotri Essent Fatty
Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical activity
of procyanidins. Supplement of Planta Medica, Journal of Medicinal Plant
Research and Journal of Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications
in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106.
Masquelier, J. Les procyanidols du vin leur role dans lalcoolisme.
pp. 88-93.
Gazave, J.M. Notions recentes sur les capillaires
unpub. bulletin
from the Laboratoire De Physiologie Patholigie pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation and
atherothrombosis.
Office International Vigne et du Vin, Nutrition and Health Unit, Paris France;
Drugs under Experimental and Clinical Research (Switz.) 25/2-3 (125-131),
1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of
procyanidin. Acta Physiologica
Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur lhyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en
gynecologie. Essai
Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P Une Etude Exemplaire Pour Un
Phlebotrope: letude EIVE. Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon decobaye.
Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. Collagen treated with (+)
-catechin becomes resistant to the action of mammalian
collagenase.
Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col.
of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. Effect protecteur des oligomeres
procyanidoliques sur le lathyrisme experimental chez le rat. Ann.
Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal circulation.
Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr.
Opthalmol,
(11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling:
use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4,
177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside oligomers
effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93,
1988.
Saracco, J.B., Estachy, G.M. Etude d lEndotelon en
opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr.
Opthalmol, 11:453,
1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et
O.P.C. Bordeaux Medicale,
(16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and
hemorheology. Bull
Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. Les oligomeres procyanidoliques dans le traitement de
la fragilite capillaire et de la retinopathie chez les diabetiques. A propos
de 26 cas. Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a letude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results of a double-blind
study versus placebo in 32 female patients. Ann Chir Plast Esthet 29(4):393-5,
1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism in
rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels.
Angiologica,
9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer, H.J. Berkhauser
Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977.
Masquelier, J. Action protectrice du vin sur lulcere
gastrique. Resultats,
p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by flavonoids
and bioflavonoids. Planta Medica, 5116-20, 1985.
Packer, L., et al. The antioxidant miracle: your complete plan. John Wiley
& Sons, Inc., 1999.
Shaw, R. How [Australian] PycnoGenol [MASQUELIERs®] Helps Sports
People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums Cosmet
Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques (Endotelon) dans le traitement des lymphoedemes
post-therepeutiques de members superieurs. Symposium Satellite, Congres International dAngiologie,
Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during 2 weeks
of intense training. Abstract submitted to national meeting of the Amer
College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting by
chronic phosphatidylserine administration of the stress-induced activation
of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm
43: 385388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced overtraining.
Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques
sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux,
1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur loxydation
de lacide ascorbique par les ions cuivriques. Bull. de la Societe
de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur lacide
ascorbique-oxydase. Bull. de la Societe de Chimie Biologique XXXIII (3,4)
1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G.,
Mishioka,
I. Inhibitory effects of tannins on hyaluronidase activation and on
the degranulation from rat mesentery mast cells. Chem. Pharm. Bull.
33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J. Histamine
and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress
ulcer formulation by (+)-catechin, an inhibitor of specific histidine decarboxylase
in vitro. Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. Les oedemes
post-traumatoqies
chez le sportif: essai controle de lEndothelon. Actualite Therapeutique
90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. Flavonoids et Pycnogenols Int J Vit Nut
Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol.
25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow cells
of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co., projects
143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research, Inc., Hanover,
Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable
extracts to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux,
129:51-65, 1990.
|
|